Consolidated Portfolio Review Corp’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,666
Closed -$7.94M 403
2025
Q3
$7.94M Sell
30,666
-1,568
-5% -$393K 1% 14
2025
Q2
$8M Sell
32,234
-1,695
-5% -$419K 1.11% 13
2025
Q1
$8.98M Sell
33,929
-707
-2% -$188K 1.44% 11
2024
Q4
$8.79M Sell
34,636
-1,098
-3% -$296K 1.39% 10
2024
Q3
$10.1M Sell
35,734
-294
-0.8% -$81.7K 2.25% 6
2024
Q2
$9.58M Buy
36,028
+3,562
+11% +$934K 2.24% 7
2024
Q1
$8.78M Sell
32,466
-7,236
-18% -$1.9M 2.3% 4
2023
Q4
$9.95M Sell
39,702
-7,075
-15% -$1.68M 2.27% 4
2023
Q3
$11M Sell
46,777
-1,827
-4% -$445K 2.67% 3
2023
Q2
$11.9M Sell
48,604
-163
-0.3% -$39.7K 2.83% 3
2023
Q1
$11.6M Buy
+48,767
New +$11.7M 3.15% 2

Other funds holding VHT

Consolidated Portfolio Review Corp's VHT Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Vanguard Health Care ETF (VHT) in Q4 2025, closing a stake of 30,666 shares — an estimated $7.94M sold.

Consolidated Portfolio Review Corp first reported a position in VHT in Q1 2023 and held it in 11 quarters. The position peaked at $11.9M in Q2 2023. 1,132 funds tracked by Wall St. Rank hold VHT as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Vanguard Health Care ETF position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 30,666 Vanguard Health Care ETF shares in Q4 2025, an estimated $7.94M.
  • Consolidated Portfolio Review Corp first reported a position in Vanguard Health Care ETF in Q1 2023 and held it in 11 quarters.
  • Consolidated Portfolio Review Corp's Vanguard Health Care ETF position peaked at $11.9M in Q2 2023.
  • 1,132 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.